Report Open Access

HAO1 inhibitor development: Screening of follow-up compounds from fragment hits by fluorescence-based activity assay - part 1 of 2

Mackinnon, Sabrina; Yue, Wyatt, W; Brennan, Paul

This is part of the Open Lab Notebook initiative. To read the associated post please click here.

 

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
191
71
views
downloads
All versions This version
Views 191191
Downloads 7171
Data volume 140.6 MB140.6 MB
Unique views 163163
Unique downloads 6666

Share

Cite as